Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 14, 2018

Total Value ($000): $186,623 (100.0% shares, 0.0% debt)

Holdings (30)

— BIOSPECIFICS TECHNOLOGIES 14.0%

Value ($000) $26,162 Shares 590,025 Est. Cost $45.13 Unrealized —

— CTI BIOPHARMA CORP 10.7%

Value ($000) $20,053 Shares 5,141,746 Est. Cost $3.59 Unrealized —

— AMARIN CORP PLC -ADR 9.3%

Value ($000) $17,342 Shares 5,761,581 Est. Cost $3.01 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 8.9%

Value ($000) $16,590 Shares 984,584 Est. Cost $14.90 Unrealized +12.3%

— APOLLO ENDOSURGERY INC 8.7%

Value ($000) $16,151 Shares 2,577,996 Est. Cost $4.75 Unrealized —

— VIVEVE MEDICAL INC 7.5%

Value ($000) $14,090 Shares 3,849,711 Est. Cost $6.92 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 4.7%

Value ($000) $8,838 Shares 1,323,041 Est. Cost $5.83 Unrealized +18.2%

— BIODELIVERY SCIENCES INTL 4.5%

Value ($000) $8,339 Shares 3,706,084 Est. Cost $2.06 Unrealized —

— CARDIOME PHARMA CORP 4.0%

Value ($000) $7,520 Shares 3,241,550 Est. Cost $2.49 Unrealized —

— NOVELION THERAPEUTICS INC 3.5%

Value ($000) $6,510 Shares 1,860,000 Est. Cost $8.14 Unrealized —

— ALIMERA SCIENCES INC 3.4%

Value ($000) $6,365 Shares 6,180,033 Est. Cost $1.20 Unrealized —

— DOVA PHARMACEUTICALS INC 2.7%

Value ($000) $4,990 Shares 184,000 Est. Cost $27.12 Unrealized —

— OPHTHOTECH CORP 2.3%

Value ($000) $4,365 Shares 1,593,119 Est. Cost $4.39 Unrealized —

VCYT VERACYTE INC 2.3%

Value ($000) $4,303 Shares 773,889 Est. Cost $7.51 Unrealized -17.6%

— CONFORMIS INC 2.2%

Value ($000) $4,028 Shares 2,777,711 Est. Cost $1.45 Unrealized —

— OXFORD IMMUNOTEC GLOBAL PLC 1.8%

Value ($000) $3,286 Shares 263,974 Est. Cost $12.45 Unrealized —

— CANCER GENETICS INC 1.6%

Value ($000) $2,925 Shares 1,772,741 Est. Cost $1.85 Unrealized —

— MEDICREA INTERNATIONAL 1.5%

Value ($000) $2,778 Shares 714,729 Est. Cost $3.60 Unrealized —

— STEADYMED LTD 1.3%

Value ($000) $2,344 Shares 721,308 Est. Cost $3.64 Unrealized —

— INVUITY INC 1.0%

Value ($000) $1,952 Shares 507,028 Est. Cost $3.85 Unrealized —

— GEMPHIRE THERAPEUTICS INC 0.8%

Value ($000) $1,581 Shares 242,812 Est. Cost $6.51 Unrealized —

— SIERRA ONCOLOGY INC 0.6%

Value ($000) $1,182 Shares 570,987 Est. Cost $2.07 Unrealized —

— INVITAE CORP 0.6%

Value ($000) $1,027 Shares 219,022 Est. Cost $4.69 Unrealized —

— ZOSANO PHARMA CORP 0.5%

Value ($000) $1,008 Shares 200,000 Est. Cost $5.04 Unrealized —

— FOAMIX PHARMACEUTICALS LTD 0.4%

Value ($000) $666 Shares 129,756 Est. Cost $5.13 Unrealized —

EOLS EVOLUS INC 0.3%

Value ($000) $535 Shares 59,229 Est. Cost $11.44 Unrealized 0.0%

— IMMUNE DESIGN CORP 0.3%

Value ($000) $532 Shares 161,226 Est. Cost $3.30 Unrealized —

— SCYNEXIS INC 0.3%

Value ($000) $509 Shares 380,083 Est. Cost $1.34 Unrealized —

— EYENOVIA INC 0.2%

Value ($000) $365 Shares 39,902 Est. Cost $9.15 Unrealized —

— AQUINOX PHARMACEUTICALS INC 0.2%

Value ($000) $287 Shares 20,374 Est. Cost $11.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BIOSPECIFICS TECHNOLOGIES	590,025	$26,162	14.0%	$45.13	—	COM	090931106
—	CTI BIOPHARMA CORP	5,141,746	$20,053	10.7%	$3.59	—	COM NEW	12648L601
—	AMARIN CORP PLC -ADR	5,761,581	$17,342	9.3%	$3.01	—	SPONS ADR NEW	023111206
VNDA	VANDA PHARMACEUTICALS INC	984,584	$16,590	8.9%	$14.90	+12.3%	COM	921659108
—	APOLLO ENDOSURGERY INC	2,577,996	$16,151	8.7%	$4.75	—	COM	03767D108
—	VIVEVE MEDICAL INC	3,849,711	$14,090	7.5%	$6.92	—	COM NEW	92852W204
CPIX	CUMBERLAND PHARMACEUTICALS	1,323,041	$8,838	4.7%	$5.83	+18.2%	COM	230770109
—	BIODELIVERY SCIENCES INTL	3,706,084	$8,339	4.5%	$2.06	—	COM	09060J106
—	CARDIOME PHARMA CORP	3,241,550	$7,520	4.0%	$2.49	—	COM NO PAR	14159U301
—	NOVELION THERAPEUTICS INC	1,860,000	$6,510	3.5%	$8.14	—	COM NEW	67001K202
—	ALIMERA SCIENCES INC	6,180,033	$6,365	3.4%	$1.20	—	COM	016259103
—	DOVA PHARMACEUTICALS INC	184,000	$4,990	2.7%	$27.12	—	COM	25985T102
—	OPHTHOTECH CORP	1,593,119	$4,365	2.3%	$4.39	—	COM	683745103
VCYT	VERACYTE INC	773,889	$4,303	2.3%	$7.51	-17.6%	COM	92337F107
—	CONFORMIS INC	2,777,711	$4,028	2.2%	$1.45	—	COM	20717E101
—	OXFORD IMMUNOTEC GLOBAL PLC	263,974	$3,286	1.8%	$12.45	—	ORD SHS	G6855A103
—	CANCER GENETICS INC	1,772,741	$2,925	1.6%	$1.85	—	COM	13739U104
—	MEDICREA INTERNATIONAL	714,729	$2,778	1.5%	$3.60	—	COM	F6112U109
—	STEADYMED LTD	721,308	$2,344	1.3%	$3.64	—	SHS	M84920103
—	INVUITY INC	507,028	$1,952	1.0%	$3.85	—	COM NEW	46187J205
—	GEMPHIRE THERAPEUTICS INC	242,812	$1,581	0.8%	$6.51	—	COM	36870A108
—	SIERRA ONCOLOGY INC	570,987	$1,182	0.6%	$2.07	—	COM	82640U107
—	INVITAE CORP	219,022	$1,027	0.6%	$4.69	—	COM	46185L103
—	ZOSANO PHARMA CORP	200,000	$1,008	0.5%	$5.04	—	COM NEW	98979H202
—	FOAMIX PHARMACEUTICALS LTD	129,756	$666	0.4%	$5.13	—	SHS	M46135105
EOLS	EVOLUS INC	59,229	$535	0.3%	$11.44	0.0%	COM	30052C107
—	IMMUNE DESIGN CORP	161,226	$532	0.3%	$3.30	—	COM	45252L103
—	SCYNEXIS INC	380,083	$509	0.3%	$1.34	—	COM	811292101
—	EYENOVIA INC	39,902	$365	0.2%	$9.15	—	COM	30234E104
—	AQUINOX PHARMACEUTICALS INC	20,374	$287	0.2%	$11.75	—	COM	03842B101